(Q46395865)

21 December 2017

title

Drug-eluting stents: is new necessarily better? (English)

1 reference

21 December 2017

1

Ron Waksman

1 reference

21 December 2017

language of work or name

English

0 references

publication date

31 August 2008

1 reference

21 December 2017

published in

The Lancet

1 reference

21 December 2017

volume

372

1 reference

21 December 2017

issue

9644

1 reference

21 December 2017

page(s)

1126-1128

1 reference

21 December 2017

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961245-3

7 January 2021

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961245-3

7 January 2021

Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961245-3

7 January 2021

Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961245-3

7 January 2021

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961245-3

7 January 2021

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961245-3

7 January 2021

Endothelial cell recovery between comparator polymer-based drug-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961245-3

7 January 2021

Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961245-3

7 January 2021

Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel meeting on the endeavor zotarolimus-eluting coronary stent

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961245-3

7 January 2021

BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961245-3

7 January 2021

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961245-3

7 January 2021

Outcomes and complications associated with off-label and untested use of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961245-3

7 January 2021

10.1016/S0140-6736(08)61245-3

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017